The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...] …
Year: 2024
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After a long period in which many 340B providers felt helpless, the last month has brought two major wins. First, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Where did you grow up?
Pleasanton, CA
Q: Where did you go to college/graduate school?
University of California Davis
Q: What are your favorites?
Food: I love to cook so it’s hard to pick one thing. My kids’ favorite home cooked meal is my Italian risotto recipe.
Movie: …
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
We understand that referrals are often the grayest area of your 340B program. That’s why we’ve been building technology and teams specifically focused on referral capture for more than a decade. As we engage with clients, we pay close attention to what
…
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...] …
